Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a digital battery sharpen detection of brain injury aftermath?

NCT ID NCT06830291

Diagnosis Sponsor: Direction Centrale du Service de Santé des Armées Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 28, 2026 · Last updated Aug 28, 2026

Summary

This study tests a digital tool called Neuralix, designed to assess memory and thinking skills in adults who have had moderate to severe head trauma. Researchers will check how well the battery detects cognitive issues in patients and compare results with healthy volunteers to set standard scores. The goal is to provide a more accurate and reliable way to evaluate brain function after injury.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Neuralix digital cognitive assessment battery
What this could lead to
If validated, this digital tool could give clinicians a more accurate way to detect and track cognitive problems after head trauma, improving patient care.
What could go wrong
This is a validation study, not a treatment trial, so it won't directly change outcomes. The battery may still miss some cases or be less accurate in real-world settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 800 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2025

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with TBI moderate to severe vs controls

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * French-speaking subject aged 18 to 65 years old * Signed consent to participate * History of head trauma of moderate to severe intensity, i.e. having presented the high risk criteria of the study by Masters et al. (1987) at the time of the head trauma, and occurred a maximum of 5 years after inclusion in the VANOLIX study Exclusion Criteria: * Visual or hearing or motor deficit disrupting the taking of cognitive tests * Subject with insufficient knowledge of counting (up to 25), the alphabet, reading, or French writing * Subject with a severe intellectual disability * Subject with past psychiatric or behavioral disorders requiring a stay \>2 days in a specialized environment or requiring current treatment other than a single anxiolytic * Current treatment with antidepressant * Current treatment with antipsychotic or multiple anxiolytics * Single anxiolytic treatment initiated or increased for less than 1 month or current antiepileptic treatment * Subject with a neurological condition or a history leading to cerebral dysfunction likely to interfere with the cognitive assessment

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Traumatic brain injuries are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Brain Injuries, Traumatic traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Traumatic brain injuries

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hôpital d'Instruction des Armées - Percy

    RECRUITING

    Clamart, 92140, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.